Patents Assigned to Venture Technologies SDN BHD
  • Flavivirus NS1 subunit vaccine
    Patent number: 8815501
    Abstract: The present invention relates to NS1 proteins or parts thereof of Flaviviruses, in particular of Dengue viruses useful for vaccination against said Flavivirus and against one or more other Flaviviruses. The invention further concerns the NS1 protein or parts thereof of one Dengue virus serotype, in particular serotype 2, useful for vaccination against Dengue viruses from all serotypes. The invention further concerns DNA comprising an expression cassette coding for a Flavivirus NS1 or parts thereof, vectors comprising said DNA and vaccines containing or expressing a Flavivirus NS1.
    Type: Grant
    Filed: June 19, 2009
    Date of Patent: August 26, 2014
    Assignees: Bavarian Nordic A/S, Venture Technologies SDN BHD
    Inventors: Paul Howley, Sonja Leyrer, Mary Jane Cardosa, Magdeline Sia Henry Sum
  • MVA virus vector expressing dengue NS1 protein
    Patent number: 7759116
    Abstract: The present invention relates to NS1 proteins or parts thereof of Flaviviruses, in particular of Dengue viruses useful for vaccination against said Flavivirus and against one or more other Flaviviruses. The invention further concerns the NS1 protein or parts thereof of one Dengue virus serotype, in particular serotype 2, useful for vaccination against Dengue viruses from all serotypes. The invention further concerns DNA comprising an expression cassette coding for a Flavivirus NS1 or parts thereof, vectors comprising said DNA and vaccines containing or expressing a Flavivirus NS1.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: July 20, 2010
    Assignees: Bavarian Nordic A/S, Venture Technologies SDN BHD
    Inventors: Paul Howley, Sonja Leyrer, Mary Jane Cardosa, Magdeline Sia Henry Sum